EUVIMEDEUVIMED entdecken
Fallbericht

Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction

Connie R Shi, Michael Shaughnessy, Kartik Sehgal, John R Clark, Kerry L Reynolds, Jennifer Toyohara, Steven T Chen

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16572 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Connie R Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Exanthema. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Dermatology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atypical presentations of Stevens-Johnson syndrome/Toxic epidermal necrolysis (SJS/TEN)-like eruptions 1 have been observed in association with immune checkpoint inhibitors (ICIs)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stevens-Johnson SyndromeExanthemaHumansAntibodies, Monoclonal, Humanized

Substanzen

pembrolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
  • Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Adult & Pediatric Dermatology, PC, Concord, MA, USA.

Förderung

  • Dermatology Foundation

Zitieren

APA

Shi, C. R., Shaughnessy, M., Sehgal, K., Clark, J. R., Reynolds, K. L., Toyohara, J., & Chen, S. T. (2023). Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction. International Journal of Dermatology. https://doi.org/10.1111/ijd.16572

Vancouver

Shi CR, Shaughnessy M, Sehgal K, Clark JR, Reynolds KL, Toyohara J, et al. Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction. International Journal of Dermatology. 2023. doi:10.1111/ijd.16572

BibTeX
@article{Shi2023,
  author = {Shi, Connie R and Shaughnessy, Michael and Sehgal, Kartik and Clark, John R and Reynolds, Kerry L and Toyohara, Jennifer and Chen, Steven T},
  title = {Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16572}
}
Kostenlos starten →